← Back to Search

Cognitive Behavioral Therapy for Suicide Prevention in Psychosis

N/A
Recruiting
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged between 18 to 65 years
Suicide ideation and/or attempt within 3 months of screening
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-months after baseline
Awards & highlights

Study Summary

This trial will test a modified form of Cognitive Behavioral Therapy specifically for people with suicidal thoughts or behaviors due to a schizophrenia spectrum disorder, to see if it is more effective than usual care.

Who is the study for?
This trial is for English-speaking adults aged 18-65 with a schizophrenia spectrum disorder who have had suicidal thoughts or behaviors in the last 3 months. It's not suitable for those needing emergency care, with impaired cognitive capacity, or deemed inappropriate for behavioral treatment.Check my eligibility
What is being tested?
The study tests Cognitive Behavioral Suicide Prevention tailored for psychosis (CBSPp) against standard services (SAU). Participants will be randomly assigned to one of these two groups and evaluated over five months through interviews and assessments.See study design
What are the potential side effects?
Since this trial involves psychological therapy rather than medication, typical side effects associated with drugs are not expected. However, discussing sensitive topics like suicide may cause emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I have not had thoughts or attempts of suicide in the last 3 months.
Select...
I have been diagnosed with a schizophrenia spectrum disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-months after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-months after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Calgary Depression Rating Scale (CDRS) change from baseline
Columbia Suicide Severity Rating Scale (C-SSRS) change from baseline
Positive and Negative Syndrome Scale (PANSS) change from baseline
Secondary outcome measures
Beck Hopelessness Scale change from baseline
Defeat Scale (D Scale) change from baseline
Resilience Appraisals Scale (RAS) change from baseline
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive Behavioral Suicide Prevention for psychosis (treatment group)Experimental Treatment1 Intervention
Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) is a behavioral treatment and will be delivered in 10 weekly individual therapy sessions in addition to standard/current services.
Group II: Services as Usual (SAU; comparison group)Active Control1 Intervention
Services as usual involve standard and current services that clients are eligible for receiving.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,798 Previous Clinical Trials
6,378,066 Total Patients Enrolled
2 Trials studying Psychosis
237 Patients Enrolled for Psychosis
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,627 Total Patients Enrolled
46 Trials studying Psychosis
10,647 Patients Enrolled for Psychosis

Media Library

Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) Clinical Trial Eligibility Overview. Trial Name: NCT05345184 — N/A
Psychosis Research Study Groups: Cognitive Behavioral Suicide Prevention for psychosis (treatment group), Services as Usual (SAU; comparison group)
Psychosis Clinical Trial 2023: Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) Highlights & Side Effects. Trial Name: NCT05345184 — N/A
Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05345184 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are older individuals being considered as participants in this investigation?

"Enrolment for this medical trial is restricted to individuals aged 18-65."

Answered by AI

Are investigators currently accepting new participants for this research endeavor?

"Indeed, pertinent information on clinicaltrials.gov reveals that this study is still recruiting participants. It was initially posted to the site on September 1st 2022 and has most recently been updated October 27th of this year. 72 individuals need to be recruited from one medical centre for it to reach completion."

Answered by AI

What objectives has this research endeavor been designed to fulfill?

"This trial's main assessment point is the alteration in C-SSRS scores over a three month period. Supplementary measures of efficacy include alterations in Beck Hopelessness Scale, Suicide Stroop Task results, and Resilience Appraisals Scale ratings."

Answered by AI

What is the recruitment size of this trial?

"Affirmative. As evidenced on clinicaltrials.gov, this trial commenced recruiting after it was first posted online on September 1st 2022 and has been revised recently (October 27th 2022). Seventy two participants are needed for the study to take place in one specified site."

Answered by AI

Is it feasible to join this clinical investigation?

"This medical trial is recruiting 72 individuals aged between 18 and 65 who have experienced suicidal thoughts or actions within the past 3 months. Other prerequisites for participation include a Schizophrenia Spectrum Disorder diagnosis, the ability to comprehend English, both written and verbal."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Cognitive Behavioral Suicide Prevention for Psychosis: Aim 2
Lindsay Bornheimer 2022. "Cognitive Behavioral Suicide Prevention for Psychosis: Aim 2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05345184.
~0 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top